Andrew Christie
Direttore/Membro del Consiglio presso HELIOS UNDERWRITING PLC
Patrimonio netto: 76 323 $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Thomas Libassi | M | 66 | 3 anni | |
| Ben Mingay | M | 58 |
Smith Square Partners LLP
 Smith Square Partners LLP Investment ManagersFinance Smith Square Partners LLP provides corporate finance advisory services. It offers its services to corporations, private equity firms, investors and entrepreneurs. The firm specializes in public company takeovers, company acquisitions and sales, advising on capital markets transactions, refinancing and restructuring, and management advice. The company was founded by Benjamin Edward Mingay in 2010 and is headquartered in London, the United Kingdom. | 14 anni |
| Arthur Manners | M | 65 | 9 anni | |
| Nigel Hanbury | M | 67 | 12 anni | |
| Paul Waterman | M | 60 | 8 anni | |
| Ralph Hewins | M | 61 | 8 anni | |
| Dorothée Anna Deuring | F | 56 | 7 anni | |
| Michael J. Wade | M | 82 | 1 anni | |
| Alexander Phillips | M | 54 |
Smith Square Partners LLP
Smith Square Partners LLP Investment ManagersFinance Smith Square Partners LLP provides corporate finance advisory services. It offers its services to corporations, private equity firms, investors and entrepreneurs. The firm specializes in public company takeovers, company acquisitions and sales, advising on capital markets transactions, refinancing and restructuring, and management advice. The company was founded by Benjamin Edward Mingay in 2010 and is headquartered in London, the United Kingdom. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Andrew Duff | M | 65 | 7 anni | |
| Ian Brindle | M | 80 | 9 anni | |
| Harold Cunningham | M | 77 | - | |
| Brian G. Taylorson | M | 68 | 14 anni | |
| Robert G. Beeston | M | 82 | 7 anni | |
| Edward Fitzalan-Howard | M | 68 | 6 anni | |
| Sandra Lynne Boss | F | 57 | 3 anni | |
| Wolfgang Plischke | M | 72 |
Ark Therapeutics Group Plc
 Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 7 anni |
| Steve Good Good | M | 63 | 10 anni | |
| Martin Reith | M | 59 | 3 anni | |
| Jeremy Evans | M | 66 | 14 anni | |
| Anne Philomena Hyland | F | 64 | 9 anni | |
| David W. Dutro | M | 68 | 18 anni | |
| Christopher Girling | M | 70 | 8 anni | |
| Nick Salmon Salmon | M | 72 | 6 anni | |
| David Philip Bloxham | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 4 anni |
| Kevin Roger Kenneth Matthews | M | 60 | 9 anni | |
| Ken Morris | M | - | - | |
| Rob Mangold | M | - | - | |
| Wendi Weber | M | - | 2 anni | |
| Ken Smith | M | - | - | |
| Robert Sklans | M | - | 2 anni | |
| Iain Ross | M | 71 |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 5 anni |
| Martha Bruce | F | - | 10 anni | |
| Brad Rector | M | - | - | |
| Russell Banks | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | - |
| Nigel Richard Parker | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 13 anni |
| David Bowyer | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 7 anni |
| Mark H. Richmond | M | 93 |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 13 anni |
| Dennis Turner | M | - |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | 10 anni |
| Paul Lumbis | M | - | 3 anni | |
| James Michael Yorrick Oliver | M | 83 | - | |
| Greg Bellotti | M | - | 9 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Regno Unito | 42 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Andrew Christie
- Contatti personali
